Jack Young’s Post

With patient centricity and "value added" solutions more in focus for pharma than ever before, we expect 2024 to be a year in which medical affairs take an even greater role in pharma communications. We would love this to be the year that silos across pharma functions are broken down for good, with cross collaboration between sales, marketing and medical affairs to increase value for patients and healthcare professionals across all that pharma does. What do you feel the challenges will be to more customer centric decision making? #pharma #medaffairs #Digital #healthcare #medcomms

Is Medical Affairs the Hidden Powerhouse of Biopharma? 5 Compelling Reasons It's Shaping the Future In an era where trust in pharma is under scrutiny, could Medical Affairs be the key to transformation? Here's why I believe it's time to put Medical Affairs in the driver's seat: Trust Builders: Bridging science and clinical practice, rebuilding industry credibility. RWE Revolutionaries: Leveraging real-world evidence to improve patient outcomes. Patient Voice Amplifiers: Putting patients at the center. Cross-Functional Maestros: Breaking silos, driving innovation. MA-led collaborations have accelerated personalized therapy development. Ethical Compass: Upholding standards even under pressure. Is it time we recognize the strategic value of Medical Affairs? What's your experience? #MedicalAffairs #Biopharma #HealthcareInnovation #PatientCentricity

🌟 Attention Pharma Leaders! Are you grappling with the absence of a Medical Affairs department in your organization? 🌟 The lack of a robust Medical Affairs presence can be a significant challenge in engaging Healthcare Professionals (HCPs) and Key Opinion Leaders (KOLs), ultimately impacting patient outcomes. But fret not, because Medcafe Solutions has just unveiled a game-changing solution! 📚 Introducing "Medical Affairs Consultation" - a revolutionary concept outlined in our latest White Paper: "Strategic Medical Affairs Outsourcing: A Pragmatic Solution in A Fast-Changing and Resource-Constrained World." 🔗 Dive into the insights: https://zurl.co/dRHr 🎥 Want an in-depth understanding? Register for our exclusive video explanation: https://zurl.co/oitS At Medcafe Solutions, we recognize the dynamic challenges faced by life sciences and Pharma organizations. . 💪🏥 🤝 Connect with us now for End-to-End Tailored Medical Affairs Consultation Services. Let's shape the future of healthcare together! 🌐✨ #MedicalAffairs #InnovationInHealthcare #MedcafeSolutions #HealthcareTransformation #LifeSciences #ConsultationRevolution

Medical Affairs teams need help. Staying up-to-date on the latest therapeutic area, product safety & efficacy information, differentiation, and competitive intelligence is a daunting task. But their job doesn't end there. This information must be collected, analyzed, sometimes distilled, and then used to educate both internal and external stakeholders, inform strategy, and improve patient outcomes. Outsourcing some of these responsibilities might be common practice, but it is not the answer. Medical affairs teams need a unified evidence base that allows them to surface and share high-value insights, answer critical questions, and, perhaps most importantly, quantify the impact of their initiatives. Advancements in AI have made this unified evidence base a reality and Sorcero is leading the charge.

Is #biotech missing a BIG opportunity in #medicalaffairs?    I speak often with biotech product leaders and regularly hear "we're not at Phase 3, so we don't need to think about medical affairs yet".   Would you be surprised to hear that thought leaders in the Medical Affairs Professional Society (MAPS) community recommend incorporating medical affairs ~5 years prior to launch? Particularly in cases where: 💡 You have a novel mechanism of action 💡 Disease awareness is low 💡 Existing literature base is insufficient 💡 You have limited engagement with external stakeholders, such as patient advocacy groups and KOLs Planning for and implementing a medical affairs strategy early can provide a number of benefits: ✔ Understanding knowledge gaps ✔ Creating awareness in the market ✔ Priming market for launch ✔ Engaging key stakeholders ✔ Building a literature base around the core clinical development cycle ✔ Measuring baseline insights ✔ Engaging investors ✔ Creating a medical affairs infrastructure If you're a biotech or biopharm in Phase 2 and want to plan for launch excellence, drop me a message and let's chat over a cuppa.

📌 Not all #insights are created equal? ✍️ There are several categories of insights that we focus on in Medical Affairs, and I will share with you 3 of them. 1. The first is clinical insights—these are directly related to patient outcomes and treatment efficacy. 2. Then, we have competitive insights, which help us understand what other players in the market are doing. - Regulatory insights give us a sense of the evolving guidelines and compliance requirements. 3. Lastly, we have patient insights—arguably the most crucial—providing us with a real-world understanding of patient experiences and needs. 👉 Each of these categories plays a key role in shaping our strategies and taking informed Decisions in #medicalaffairs 👀 You can check previous posts on how we can communicate with KOLs effectively to get these insights #KOL #MSL #medicalaffairs

Fueling Innovation: Supporting Investigator-Initiated Studies! Discover how Leader Biotech Pharma Medical Affairs Management team empowers researchers to turn groundbreaking ideas into reality. Explore our services and join us in advancing healthcare together. We are Innovating Tomorrow, Today! Contact us at marketing@leaderbiotechpharma.com for more info! #LeaderBiotechPharma #MedicalResearch #ResearchSupport #HealthcareAdvancements #MedicalPioneers #FutureOfMedicine #LifeChangingScience #ResearchToReality #MedicalBreakthroughs #PatientCare #HealthcareInnovation #FutureOfHealthcare #MedicalAdvancements #TranslationalResearch #PatientCare #ClinicalTrials #NovelTherapeutics #HealthcareRevolution #InnovatingHealthcare #GlobalHealth #CuttingEdgeSolutions #HealthcareLeaders #JoinOurJourney #InnovatingTomorrowToday

🚀 Elevating Healthcare Excellence: A Glimpse into our Mid-Year (Q2) Cycle meeting Dear LinkedIn Family, I am thrilled to share insights from our recent Cycle Meeting at Macter International Limited, where we took another giant stride in advancing patient-centric healthcare. Our teams united to chart the course groundbreaking products. Assuring that these innovations are poised to reshape the medical landscape. 💎👥 Macter Values and behaviors: Embracing Macter’s Values and Behaviors. I extend my deepest appreciation to the entire Macter family and our visionary leadership for fostering an environment of Respect, Integrity, Innovation, Collaboration and Excellence (RIICE). 🎓 Training Sessions: Conducted training for these cutting-edge launches was both an honor and a responsibility. Blending product knowledge, brand strategy, and medico-marketing insights. The focus was on empowering our teams with a deep understanding of the products, ensuring seamless integration into the market. 💡 Innovative Practice Sessions: Interactive detailing sessions and strategic planning discussions, we groomed our skills, aligning our efforts with the dynamic healthcare landscape. 🌟 Strategic Medico-Marketing: The medico-marketing strategy was a focal point. Collaborating closely with the marketing team, we ensured that our approach not only met regulatory requirements but also resonated with the scientific community and healthcare professionals. 🔍 Balancing Innovation and Compassion: In line with Macter's Vision, we believe in not just selling products but creating champions of innovation and compassion. The detailing practice, a core part of our training, challenges our representatives to become true masters in their field. Stay tuned for updates on our journey to redefine healthcare. #HealthcareInnovation #MedicoMarketing #TrainingAndDevelopment #Pharmaceuticals #StrategicPlanning #PatientCentricity #salesandmarketing #HealthcareRevolution Macter International Limited #medicalaffairs #pharmacovigilance #medicaladvisor #msls

In Medical Affairs, Advisory Board Meetings are a widely used tactic. 👥💬💡 But... ... their success largely depends on how well they are planned and executed ❗ 📽️ In the below 2-min video, CELforPharma faculty member Maaike Addicks, MD reveals the 𝟵 𝘀𝘁𝗲𝗽𝘀 𝘁𝗼 𝗮 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗔𝗱𝘃𝗶𝘀𝗼𝗿𝘆 𝗕𝗼𝗮𝗿𝗱 𝗠𝗲𝗲𝘁𝗶𝗻𝗴: 1️⃣ Set clear objective 2️⃣ Select participants 3️⃣ What's in it for them? 4️⃣ Choose the right form 5️⃣ Get your timing right 6️⃣ Send clear invites 7️⃣ Smooth execution 8️⃣ Follow up 9️⃣ Evaluate and evolve 𝗗𝗼 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗲 𝘀𝗲𝗰𝗿𝗲𝘁 𝟬,𝟱 𝘀𝘁𝗲𝗽…? 👀 -------- ☝️ I am Inge 🔥 My mission: Helping Pharma managers acquire business-critical competencies to make better decisions 𝗟𝗶𝗸𝗲𝗱 𝘁𝗵𝗶𝘀 𝗽𝗼𝘀𝘁? 𝗪𝗮𝗻𝘁 𝘁𝗼 𝘀𝗲𝗲 𝗺𝗼𝗿𝗲? 🔔 Ring the bell on my Profile to get notified 🔝 Connect with me #neverstoplearning #medicalaffairs

📢 Join Syneos Health® for an insightful webinar where industry experts will unravel the complexities of early medical affairs engagement. 💡 Discover how small and mid-sized (#SMID) companies can strategically enhance their medical affairs planning, boosting asset valuation and thriving in competitive markets. Key Discussion Points: 🔍 Strategic Prioritization: Learn to maximize impact within budget constraints, ensuring each investment advances your medical affairs objectives. 🔍 Competitive Edge: Gain strategies to differentiate your brand in a competitive market, positioning your company and products for prominence. 🔍 Real-World Insights: Benefit from practical wisdom and expert guidance shared by industry leaders who have navigated similar challenges. 🔗 Learn more + register here: https://buff.ly/3yS66g1 🌟 Featured speakers: Anshu Sawhney Diego G. Rohan Gandhi #PharmaceuticalIndustry #MarketAccess #Commercialization #MedicalAffairs #Commercialization #HEOR #MarketAccess #PharmaceuticalMarketing